The tumor suppressor CYLD is downregulated in many types of cancer, including gliomas, basal cell carcinoma, melanoma, T-cell leukemia, and colon and hepatocellular carcinomas [20,40-43]. The gene discussed is CYLD; the disease is hepatocellular carcinoma.